|
|
|
|
|
|
Alexion Pharm Inc (ALXN)
|
|
142.82 -0.10 (-0.07%)
|
9/22/2017 4:00pm
|
|
Open:
|
142.43
|
Pre. Close:
|
142.92
|
|
High:
|
143.21
|
Low:
|
141.46
|
|
Volume:
|
985,622
|
Market Cap:
|
31.88B
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
143.91 - 146.01
|
146.01 - 147.76
|
|
Low:
|
136.81 - 138.68
|
138.68 - 140.24
|
|
Close:
|
139.56 - 142.88
|
142.88 - 145.66
|
|
|
|
|
|
|
Technical analysis (as of: 2017-09-22 4:36:43 PM)
|
|
Overall:
|
|
|
Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 174.43 One year: 203.73
|
|
Support:
|
Support1: 139.16 Support2: 132.86
|
|
Resistance:
|
Resistance1:
149.34 Resistance2: 174.43
|
|
Pivot:
|
143.90 
|
|
Moving Averages:
|
MA(5): 143.03  MA(20): 142.71
MA(100): 126.64 MA(250): 125.54
|
|
MACD:
|
MACD(12,26):
2.01 Signal(12,26,9): 2.54
|
|
%K %D:
|
%K(14,3): 42.75 %D(3): 46.85
|
|
RSI:
|
RSI(14): 55.22
|
|
52-Week:
|
High: 149.34
Low: 96.18 Change(%): 14.7
|
|
Average Vol(K):
|
3-Month: 151132
10-Days 70362
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.ALXN has closed above bottom band by 30.8%. Bollinger Bands are 68.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to ALXN's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Tue, 12 Sep 2017 02:03:30 GMT
Alexion Exits New Haven For Boston, Agrees To Repay Millions In State Aid
Mon, 18 Sep 2017 09:00:00 GMT
Alexion's Growth Appears Dead
Tue, 12 Sep 2017 14:14:05 GMT
Alexion Pharmaceuticals closing RI manufacturing plant; cutting 250 jobs
Tue, 12 Sep 2017 13:22:07 GMT
Alexion to Cut Workforce by 20%, Move Headquarters to Boston -- 2nd Update
Sun, 17 Sep 2017 09:56:15 GMT
Loss of Alexion A Blow, But Bioscience Leaders Say More Successes Possible
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
